Literature DB >> 3733533

Involvement of host macrophages in the immunoadjuvant activity of amphotericin B in a mouse fungal infection model.

A Vecchiarelli, G Verducci, S Perito, P Puccetti, P Marconi, F Bistoni.   

Abstract

We have recently reported the in vivo augmentation of resistance to experimental Candida albicans injection by amphotericin B in mice and have shown that this event is concurrent with the appearance in the spleen of a highly candidacidal cell population reactive in vitro against 51Cr-labeled yeast cells. In the present study we characterize these in vitro fungicidal effectors as macrophages and describe the conditions of amphotericin B treatment most suitable for inducing candidacidal activity. We also report that macrophages from intact mice can be activated in vitro to become cytotoxic against Candida. The possible mechanisms through which the amphotericin B activated macrophages exert their increased anti-Candida activity are also investigated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733533     DOI: 10.7164/antibiotics.39.846

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.

Authors:  N Mozaffarian; J W Berman; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

Review 2.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

3.  Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.

Authors:  E Ponce; J C Pechère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

4.  A new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cells.

Authors:  L Pitzurra; R Fringuelli; S Perito; F Schiaffella; R Barluzzi; F Bistoni; A Vecchiarelli
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

5.  Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis.

Authors:  H W Murray; S Delph-Etienne
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

6.  Immunological effects of amphotericin B and liposomal amphotericin B on splenocytes from immune-normal and immune-compromised mice.

Authors:  J J Schindler; R P Warren; S D Allen; M K Jackson
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

7.  Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats.

Authors:  R M Fielding; P C Smith; L H Wang; J Porter; L S Guo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 8.  Membrane effects of the polyene antibiotic amphotericin B and of some of its derivatives on lymphocytes.

Authors:  N Henry-Toulmé; P Sarthou; M Seman; J Bolard
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.